Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Florida Weight Loss MD vs FuturHealth

Florida Weight Loss MD
Graded #329

Lower grade

vs+5.499999999999993
FuturHealth
Graded #215

Higher grade

The verdict

FuturHealth takes it — 65.6/100 to 60.1/100.

FuturHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFuturHealth +9
51
60
Dose & formulationFuturHealth +28
53
81
Clinical oversightFlorida Weight Loss MD +11
78
67
Labs & monitoringFlorida Weight Loss MD +1
62
61
FulfillmentFlorida Weight Loss MD +5
67
62
Contract termsFuturHealth +8
47
55
Florida Weight Loss MD · left barFuturHealth · right bar

The numbers

MetricFlorida Weight Loss MDFuturHealth
WeighScore60.1/10065.6/100
GradeCC
Scorecard rank#329#215
SemaglutideNot disclosed$199/mo (compounded)
TirzepatideNot disclosedNot disclosed
Coverage1 stateCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Florida Weight Loss MD

Graded #329 · C

Strengths

  • Physician-led (Dr. Sergey Terushkin, MD, FACS) with same-day telehealth visits statewide in Florida
  • Offers both compounded GLP-1 and brand Wegovy/Ozempic/Mounjaro/Zepbound when appropriate
  • Accepts most insurance or self-pay; consult $99 with $49 applied to the program

Where it loses points

  • Florida residents only — no service outside the state
  • Monthly medication pricing is not published; disclosed after evaluation
  • Single-clinic operation rather than a national telehealth platform
FuturHealth

Graded #215 · C

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

Where it loses points

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard